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Malaria sporozoites, upon injection by an infected anopheline mosquito, are
rapidly and specifically localized in the hepatocytes of the mammalian host.
Inhibition ofinvasion by mAbs orspecific sera suggests that the circumsporozoite
(CS)' protein plays a major role in thisprocess (1-5), but the specific mechanisms
involved are not understood. We have investigated (6) the possibility that the N1
conserved region ofthe CS proteins fromPlasmodiumfalciparum and Plasmodium
knowlesi is involved in sporozoite/hepatocyte recognition. Using synthetic pep-
tides based on this region and the cloned human hepatoma cell line, HepG2-
A16, as a target cell for invasion by P. falciparum sporozoites (3), we present
evidence that P. falciparum sporozoites could use cell recognition of or by this
portion ofthe CS protein as a part of the hepatocyte invasion process. Chemical
crosslinking of radiolabeled N1 peptide to the HepG2-A16 cell line identified
two hepatocyte proteins involved in peptide recognition.
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Materials and Methods
Peptides were synthesized by the stepwise solid-phase method (7) on a multidetachable
resin (8) (p-acyloxybenzhydrylamine-copolystyrene-1 %-divinylbenzene). t-butyloxycar-
bonyl (Boc)-amino acids with benzyl alcohol-derived side chain-protecting groups were
attached on p-acyloxybenzhydrylamine resin (0.4 mmol/g) and the peptides were assem-
bled on a 990 M synthesizer (Beckman Instruments, Inc., Fullerton, CA). A double-
coupling protocol via dicyclohexylacarbodiimide was used to give a coupling efficiency of
99.7% completion per step. Cleavage of peptides was effected by the degradative depro-
tection method (8). The imidazole-DNP protecting group was removed by 1 M thiophenol
in dimethylformamide and the benzyl protecting groups by a mixture of reagent
CF,SO,H/CF,C02H/CH-,SCH3/p-cresol (10:50 :30 :10, vol/vol) at 10°C for 4 h. The
crude and unprotected peptide still attached to the resin was then released as peptide-p-
hydroxybenzhydrylamine by methylaminolysis in CH3NH2/ethanol/tetrahydrofurane
(10 :45 :45, vol/vol) at 20°C for 16 h.
The peptide-p-hydroxybenzhydrylamine was purified on a reverse-phase C-18 column
(2.5 X 30 cm) using aqueous CF3CO2H (0.05%) and acetonitrile (80%) gradient. In some
This work wassupportedby Agency for International Development contracts DPE-0453-C-00-3051-
00 and DPE-0453-A-00-5012-00.
' Abbreviations used in this paper:
￿
CS, circumsporozoite; DSS, disuccinyl suberimidate; ISI, inhi-
bition ofsporozoite invasion; MHBI,methyl-p-hydroxybenzimidate; PfN1, P. falciparum N1 peptide.
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PfTR5 *Tyr-[Asn-A1&-Azn-Prol5-NH2
PfNi
￿
R'-Leu-Lys-Gln-Pro-Gly-Asp-Gly-Asn-Pro-Asp-Pro-NH2
11 11 11 11 11
￿
11 11
11
11
11
PfN2 Lys-Pro-Lys-His-Lys-Lys-Leu-Lys-Gln-Pro-Gly-Asp-Gly-Asn-Pro-Asp-Pro-R"
11 11 11 11 11
￿
1 11
￿
1 11
PkN1
￿
Lys-Leu-Lys-Gln-Pro-Asn-Glu-Gly-Gln-Pro-R"
R' = Ho
FIGURE 1 . Description of peptides used for study. Sequences are aligned for maximal
homology. 11, conserved amino acids. 1, conservative amino acid substitutions. Asterisk, iodi-
nation sites.
cases the p-hydroxybenzhydrylamine handles of the peptides were removed by acid
hydrolysis in CF3S03H/CF3CO2H/p-cresol (2:88:10, vol/vol) for 1 h, and the peptides
were further purified on a reverse-phase C-18 column as described above. The purified
material gave a single symmetrical peak on analytical HPLC, and the correct molar amino
acid rations upon 6 N HCl hydrolysis. Designations and amino acid sequences for each of
the peptides are given in Fig. 1 .
To provide a phenolic site for radio-iodination, the peptide PfN I was derivatized at
the amino terminus with methyl-p-hydroxybenzimidate (MHBI ; Pierce Chemical Com-
pany, Rockford, IL) as described by Tolan et al. (9). Peptides PkNI and PfN2 were
purified with removable p-hydroxybenzhydrylamine handles that were suitable for radio-
iodination. Peptide PfTR5 contained a tyrosine residue to permit radio-iodination.
Each peptide was radiolabeled using Na1251 (Amersham Corp., Arlington Heights, IL)
and Iodogen (Pierce Chemical Co.) as previously described (10). Uncoupled iodide was
removed by passing the radiolabeled peptides through Dowex I (Sigma Chemical Co., St.
Louis, MO). Typical specific activities of radiolabeled peptides were: P. falciparum-NI
peptide (PfN 1), 3.8,uCi/pg; PfN2, 7.2 ,ACi/ug; P. knowlesi N 1 peptide (PkN I ), 5.2 pCi/pg;
and PfTR5, 8.8 ACi/kg.
Purified IgG from rabbit serum raised against the PfN 1 was generously provided by
Dr. Victor Nussenzweig, Department of Pathology, New York University Medical Center.
Human hepatoma cloned cell line HepG2-A16 was cultured in MEM (Earl's) supple-
mented with 10% FCS, 50 U/ml penicillin, and 50,ug/ml streptomycin in 5% C02 in air
at 37°C (11).
The binding of peptides to hepatoma cells was assayed by incubating peptides with cells
grown on Thermolux coverslips (LUX; Miles Laboratories Inc., Naperville, IL) in 0.45
ml complete medium and incubated in 5% C02 at 37 °C for I h. Coverslips were then
washed five times with Dulbecco's PBS (Gibco Laboratories, Grand Island, NY) and bound
peptide was determined by counting the coverslips directly in an LKB CliniGamma
counter (LKB Wallac, Turku, Finland).
P. falciparum sporozoites were isolated from the salivary glands ofAnopheles stephensi
mosquitoes fed 14 d previously on in vitro cultures of gametocytes of strain NF-54.
Inhibition of invasion assay (ISI) was performed by the addition of 30,000 sporozoites in
the medium containing control or immune serum to a confluent monolayer of hepatoma
cells on a 1-cm glass coverslip, incubating for 2.5 h, and counting invaded sporozoites as
previously described (3).
For crosslinking of peptide to associated hepatoma cell proteins, radiolabeled peptide
was incubated with cells in Earl's balanced salt solution for I h at 37 ° C in 5% C02 in air.
Cells were washed twice and incubated in Earl's salts containing 200 ug/ml of disuccinyl
suberimidate (DSS; Pierce Chemical Co.) for 20 min at 24°C. Reaction was stopped by
the addition ofexcess glycine for an additional 20 min at 24'C. The medium was removed
and the adherent cells were solubilized in 0.0625M Tris-HCI, pH 6.8, containing 10%
glycerol, 5% SDS, and 5% 2-ME. Solubilized proteins were separated by SDS-PAGE6
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FIGURE 2. Specific uptake of PkNI by HepG2-AI6 cells. ' 251-PkNI was incubated with
hepatoma cells as described in text in the presence or absence of unlabeled, homologous
peptide. Cell-associated label was plotted as a function of time. (/) '25I-PkNI, (p) 1251-PkNI
plus 10 wg PkNI per ml.
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FIGURE 3.
￿
Scatchard analysis, equating cell accumulation with binding, of various peptides
derived from either P. falciparum or P. knowlesi CS protein. Various concentrations of 1251_
peptides were incubated with hepatoma cells as described in text and cell associated and free
concentration determined directly. (A) PfNI peptide; (B) PkNI peptide; (C) P. falciparum
repeat region, Tyr-(NANP)5; (D) PfN2 region.
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according to the method of Laemmli and Favre (12), and proteins crosslinked to radiola-
beled peptide were visualized by autoradiography on XAR-5 film (Eastman Kodak Co.,
Rochester, NY) at -70°C using a Cronex Lightning plus enhancing screen (DuPont Co.,
Wilmington, DE).
Peptide Binding.
￿
Human hepatoma cells, incubated with I25I-labeled PfN1 or
PkN1, rapidly accumulated radiolabel (Fig. 2). This accumulation was largely
inhibited by the simultaneous addition of 10 Ag/ml of unlabeled peptide, indi-
cating that the process was specific and not due to random endocytic uptake.
When these data were plotted as for a Scatchard analysis, equating binding and
accumulation, similar specific binding curves were seen for N1 peptides from
either species (Fig. 3, A and B). Saturation of available receptors occurred at a1918 SYNTHETIC PEPTIDES MODEL SPOROZOITE/HEPATOCYTE INTERACTION
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FIGURE 4.
￿
ISI by IgG against the PfN 1 peptide. P. falciparum sporozoites were incubated in
the presence of Ig and the resulting invasion rate was calculated as a percentage of invasion in
the presence of normal rabbit Ig. IS15o, 20 wg IgG per ml.
concentration of ^-10,ug/ml of peptide. Binding of the NI peptides was inhibited
equally well by unlabeled peptide from either species of malaria. In combination,
the inhibition was additive, but not synergistic (data not shown).
A synthetic peptide containing five copies of the repeat sequence of the P.
falciparum CS protein, PFTR5 (Fig. 1), showed no specific (saturable) accumula-
tion by cells, although consistently high nonspecific association was seen even at
extreme concentrations of peptide (Fig. 3C). PfN2, a peptidethat contains the
entire PfNI sequence plus an additional five amino acids, including three lysine
residues, from theP. falciparum CS protein sequence, did notshow any significant
cell association, either specific or nonspecific (Fig. 3 D).
ISI Assay of Anti-PfN1.
￿
Purified rabbit IgG against PfNI was tested for
inhibition of sporozoite invasion in the ISI assay. These antibodies were strongly
inhibitory, with an ISI50 at a concentration of about 20 leg/ml (Fig. 4).
Crosslinking Studies. To identify possible hepatic cell receptor proteins,
HepG2-A16 cells previously incubated with radiolabeled NI peptide were treated
with the bifunctional reagent, DSS, to crosslink the N1 peptide with the putative
hepatocyte receptor. These cells were solubilized, and total proteins were sepa-
rated by SDS-PAGE. In the presence of crosslinker, radioactive ligand wasfound
to be covalently linked to two polypeptides with M,. of 55,000 and 35,000 (Fig.
5A). A substantial portion of the radiolabel, presumably the peptide itself, was
found near the dye front of the gel in all samples regardless of whether or not
crosslinking reagent was added (Fig. 5B). Inclusion of 10 kg/ml unlabeled
peptide in the initial incubation with PkN1 greatly reduced all cell-associated
label.
Discussion
Because of the ability of antibodies against the repeat region of the CS protein
to inhibit malaria sporozoite invasion of hepatic cells, the CS protein is thought
to have an important role in the recognition or invasion process. However,
previous work in this laboratory (Aley, S., personal communication) using either
synthetic peptides or recombinant proteins containing the tandem repeat regionFIGURE 5 .
￿
Autoradiogram of human liver cell proteinsspecifically crosslinked to radiolabeled
N1 peptide, PkN1 . HepG2-A16 cells were incubated with radiolabeled PkN1, washed, and
then treated with 200 wg/ml DSS . Unreacted DSS was blocked by addition of glycine . Proteins
were solubilized in SDS sample buffer and separated by SDS-PAGE on 10% acrylamide gels .
Proteins covalently linked to the radiolabeled N1 peptide visualized by autoradiography. (A)
1251-PkNI, crosslinked by DSS to hepatoma cell proteins . (B) '251-PkNI, without subsequent
crosslinking by DSS . Molecular weight standards are : myosin (200,000), phosphorylase B
(92,000), BSA (68,000), OVA (43,000), a-chymotrypsinogen (25,700), 0-lactoglobulin
(18,400), and bromphenol blue (B4)B) .
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of the P. falciparum CS protein failed to demonstrate any specific affinity for
liver cells .
In this study we present a sequence of about 10 amino acids (the N1 region),
immediately adjacent to the repeat of the CS protein, as a candidate for the
sporozoite ligand in hepatocyte invasion . Synthetic peptides of the amino acid
sequence from this region of either the P. falciparum or P. knowlesi CS protein
were rapidly and specifically accumulated by human liver target cell line under
conditions identical to those used for sporozoite invasion . Accumulation did not
occur with cell lines that are not readily invaded by P. falciparum (data not
shown) . This accumulation was progressively inhibited by inclusion of increasing
amounts of unlabeled ligand, giving a typical Scatchard plot and implying a
saturable, specific association . The accumulation was not associated with the
presence of the iodinatable handles on the peptides, as the peptide PfN2 also
contained a similar handle but demonstrated no binding activity toward the
hepatoma cells. The nonbinding PfN2 also contained more positively charged
amino acids, eliminating ionic interaction with the negatively charged cell surface
as a major factor . A synthetic peptide consisting of five copies of the tetrapeptide
repeat sequence from the P.falciparum CS protein likewise did not demonstrate
any specific, saturable cell association; however, this peptide did show a relatively
high nonspecific association over a broad range of concentrations .
The lack of binding by the extended P . falciparum N1 region, PfN2, has
interesting implications for the identification of the amino terminus of native CS
protein. A common feature of plasmodial sporozoites is that the malaria CS1920
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protein is processed into at least three different forms (1, 2), but the nature of
the process is as yet unknown. It is interesting to speculate that the multiple
lysine residues immediately preceding the P. falciparum N 1 region might act as
a target for proteolytic enzymes from either the mosquito salivary glands, the
sporozoite, or the host, activating the protein for binding, and that the CS
protein might not be functional in cell recognition until it is properly processed.
Inhibition of invasion by antibodies against the N1 region of the CS protein is
consistent with a major role of this region in sporozoite invasion . The concentra-
tions used for 50% inhibition are only 5-10-fold higher than those required with
highly immunogenic repeat region peptides (5). Antibodies against several syn-
thetic peptides of CS protein sequences outside of the repeat and N1 regions
were not inhibitory in similar assays (13) . Inhibition of invasion by sera against
either repeat or N1 regions may be explained in one of two ways. Because the
N1 and repeat regions are immediately adjacent there is the possibility of
antibodies against one region having steric or conformational effects on the
adjacent sequence. A more interesting possibility is that both regions are in-
volved, the repeat region providing a nonspecific affinity for cell surfaces and
the N1 region providing specific interactions, stimulatingor assisting in invasion.
In this second case the specific interactions of the N1 region would impose
stringent requirements on sequence and structure, with the result that its se-
quence is highly conserved through a wide range of species (14). The general
functions of the repeat region would, however, permit the substantial variation
in sequence seen among and within (15) species as long as the general character
was retained.
A specific ligand/receptor interaction has long been postulated to explain the
selectivity of the sporozoite for hepatocytes (16). The activities of the peptides
studied here, including specific cell interaction and immune reactivity, fulfill a
number of the criteria for that ligand. We are currently working to determine
where this protein sequence belongs in the complex scheme of hepatocyte
invasion and whether knowledge of its role would be useful to refine the
sporozoite vaccine formulations now under development.
Summary
Several lines of evidence have emphasized the importance of the malaria
circumsporozoite (CS) protein as a factor in sporozoite invasion of the hepatocyte;
however, the specific mechanism of cell recognition and invasion has not been
explained. In this study we present evidence that a highly conserved region of
the CS protein immediately adjacent to the repeat region, the N1 region,
specifically recognizes receptors on the human hepatoma cell line HepG2-A16
under conditions where invasion by sporozoites can occur. Peptides consisting of
sequences from the repeat region or of the more extensive N2 region showed
no such specific association. Antibody against the N1 peptide could inhibit
sporozoite invasion in vitro. Covalent coupling of radiolabeled N1 peptide to
HepG2-A16 cells identified two hepatic cell proteins to be closely associated with
the peptide. We suggest that these proteins could act as receptors or mediators,
via the N 1 region of the CS protein, for the P. falciparum sporozoite in the
process of invasion of the hepatocyte.We are grateful to Drs. Ruth and Victor Nussenzweig for their suggestions and encour-
agement in this work, and we wish to thank Julie Light and Linda Tsai-Huang for
excellent technical assistance.
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